» Articles » PMID: 38938228

Prenatal Congenital Heart Disease and Placental Phenotypes: Preserved Neonatal Weight Despite Small Placentas

Overview
Journal JACC Adv
Date 2024 Jun 28
PMID 38938228
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Congenital heart disease (CHD) affects 8 in 1,000 live births with significant postnatal implications including growth failure, neurodevelopmental delay, and mortality. The placenta develops concomitantly with the fetal heart. High rates of placental pathology and discordant growth in pregnancies affected by CHD highlight the significance of the fetal-placental-cardiac axis.

Objectives: This study aimed to characterize the relationship between neonatal birthweight (BW), head circumference, placental weight (PW), and placental pathology in pregnancies affected by CHD. PW:BW provides a surrogate to assess placental efficiency, or nutrient exchange and delivery by the placenta, across CHD phenotypes.

Methods: Retrospective cohort of 139 live-born singletons with postnatally confirmed CHD with placental pathology. Placental examination, infant BW, head circumference, and CHD categories (septal defects, right-sided defects, left-sided defects, conotruncal anomalies, and others) were included. Chi-square, Fisher's exact, or Kruskall-Wallis tests and multinomial logistic regressions, as appropriate.

Results: Median birthweight and head circumference percentile was 33 and 35, respectively. Placental pathology was documented in 37% of cases. PW to BW ratios were <10th percentile for 78% and <3rd percentile for 54% of the cohort, with no difference between CHD categories ( = 0.39 and  = 0.56, respectively).

Conclusions: Infants with CHD have preserved BW and head circumferences in the setting of small placentas and increased prevalence of placental pathology, suggesting placental efficiency. Detection of abnormal placental growth could add prenatal diagnostic value. Placental and neonatal discordant growth may allude to a vascular anomaly predisposing fetuses to developing CHD. Further studies are needed to explore fetal nutrient delivery and utilization efficiency.

Citing Articles

Congenital Heart Disease Fetuses Have Decreased Mid-Gestational Placental Flow, Placental Malperfusion Defects, and Impaired Growth.

Josowitz R, Ho D, Shankar S, Mondal A, Zavez A, Linn R JACC Adv. 2025; 4(2):101559.

PMID: 39898349 PMC: 11786062. DOI: 10.1016/j.jacadv.2024.101559.

References
1.
Osterman M, Hamilton B, Martin J, Driscoll A, Valenzuela C . Births: Final Data for 2020. Natl Vital Stat Rep. 2022; 70(17):1-50. View

2.
Booker W . Hypertensive Disorders of Pregnancy. Clin Perinatol. 2020; 47(4):817-833. DOI: 10.1016/j.clp.2020.08.011. View

3.
Llurba E, Sanchez O, Ferrer Q, Nicolaides K, Ruiz A, Dominguez C . Maternal and foetal angiogenic imbalance in congenital heart defects. Eur Heart J. 2013; 35(11):701-7. DOI: 10.1093/eurheartj/eht389. View

4.
Moore V, Cockington R, Ryan P, Robinson J . The relationship between birth weight and blood pressure amplifies from childhood to adulthood. J Hypertens. 1999; 17(7):883-8. DOI: 10.1097/00004872-199917070-00003. View

5.
Fung A, Manlhiot C, Naik S, Rosenberg H, Smythe J, Lougheed J . Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc. 2013; 2(3):e000064. PMC: 3698764. DOI: 10.1161/JAHA.113.000064. View